News & Updates
Showing Multidisciplinary articles
Showing

Empagliflozin improves outcomes in HFpEF patients regardless of age
Treatment with empagliflozin results in a reduction in heart failure (HF) risk and renal outcomes and in better health-related quality of life (HRQoL) among patients with chronic HF with preserved ejection fraction (HFpEF), a study has shown. In addition, the study drug is well tolerated by older patients.

Cardiovascular events not uncommon in ICU-admitted COVID-19 survivors
One out of five severe COVID-19 survivors who underwent mechanical ventilation have coronary artery disease (CAD), a quarter have subclinical left ventricular dysfunction defined as reduced echocardiographic global longitudinal strain (GLS), and 42 percent have cardiac magnetic resonance (CMR) abnormalities, reports a study.

Vedolizumab appears safe, effective in first-line treatment of ulcerative colitis in children
Children with ulcerative colitis seem to respond well to vedolizumab in the first-line setting, inducing remission without increasing the risk of adverse events, according to a small study.

Healthy lifestyle helps prevent, delay benign prostatic hyperplasia
Keeping healthy lifestyle habits, such as avoiding smoking, engaging in exercise, and limiting alcohol intake, helps prevent or delay the development of benign prostatic hyperplasia (BPH), a new Japan study has found.




